相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia
Changya Chen et al.
BLOOD (2022)
Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy
Alexandra Semchenkova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
CD5-positive marginal zone lymphoma: Clinicopathological features and survival outcomes
Yaqin Xia et al.
LEUKEMIA RESEARCH (2022)
Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia
Eleonora Khabirova et al.
NATURE MEDICINE (2022)
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukaemia
Ricky Tirtakusuma et al.
BLOOD (2022)
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch
Michaela Novakova et al.
HAEMATOLOGICA (2021)
Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group
Shinsuke Hirabayashi et al.
LEUKEMIA (2021)
Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy
Tracy Rabilloud et al.
NATURE COMMUNICATIONS (2021)
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
Antonia Malinova et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Lineage Switch in an Infant B-Lymphoblastic Leukemia With t(1;11)(p32;q23); KMT2A/EPS15, Following Blinatumomab Therapy
Jing Du et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2021)
Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia
Wenjuan Liao et al.
EXPERIMENTAL HEMATOLOGY (2021)
CD5+diffuse large B-cell lymphoma: a narrative review
Urshila Durani et al.
LEUKEMIA & LYMPHOMA (2021)
How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen
Jose Cabecadas et al.
CURRENT ONCOLOGY (2021)
De novo CD5+diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era
Bei Hu et al.
LEUKEMIA & LYMPHOMA (2020)
KSHV/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap
Francisco Vega et al.
MODERN PATHOLOGY (2020)
Blinatumomab for infant acute lymphoblastic leukemia
Katherine Clesham et al.
BLOOD (2020)
KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease
Michelle O. Forgione et al.
CANCER LETTERS (2020)
Shared D-J rearrangements reveal cell of origin of TCF3-ZNF384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL
Clara Bueno et al.
BLOOD (2020)
Flow cytometry in the diagnosis of mature B-cell lymphoproliferative disorders
Camille Debord et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Point mutation inCD19facilitates immune escape of B cell lymphoma from CAR-T cell therapy
Zhen Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia
George Mo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Immunophenotypic and molecular analysis of a B cell lymphoma with discordant light chain expression at different anatomic sites
Belinda K. Galeano et al.
JOURNAL OF HEMATOPATHOLOGY (2020)
Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure
Olivia M. Lucero et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis
Antonio Agraz-Doblas et al.
HAEMATOLOGICA (2019)
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
Mohamad Hamieh et al.
NATURE (2019)
Natural history and cell of origin of TCF3-ZNF384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL
Clara Bueno et al.
BLOOD (2019)
Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma
Haneen Shalabi et al.
HAEMATOLOGICA (2018)
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia
Matthew J. Oberley et al.
PEDIATRIC BLOOD & CANCER (2018)
Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma
Haneen Shalabi et al.
HAEMATOLOGICA (2018)
Past, Present, and Future of Rituximab-The world's First Oncology Monoclonal Antibody Therapy
Timothy M. Pierpont et al.
FRONTIERS IN ONCOLOGY (2018)
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
Elena J. Orlando et al.
NATURE MEDICINE (2018)
Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL
Matthias Woelfl et al.
BLOOD ADVANCES (2018)
ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
Shinsuke Hirabayashi et al.
HAEMATOLOGICA (2017)
ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
Shinsuke Hirabayashi et al.
HAEMATOLOGICA (2017)
CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis
Jeannette Fischer et al.
JOURNAL OF IMMUNOTHERAPY (2017)
Blinatumomab-induced lineage switch of B-ALL with t(4:11) (q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis
C. L. Haddox et al.
BLOOD CANCER JOURNAL (2017)
Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas
Naoko Tsuyama et al.
ONCOTARGET (2017)
Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights and Therapeutic Applications
Chiara Antoniani et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Antigen Loss variants: catching Hold of escaping Foes
Maulik Vyas et al.
FRONTIERS IN IMMUNOLOGY (2017)
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy
Inga Nagel et al.
BLOOD (2017)
Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution
Stephanie Guillet et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
Rebecca Gardner et al.
BLOOD (2016)
A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections
Narges Seyfizadeh et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern
Kana Sakamoto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy
Ahmad Rayes et al.
PEDIATRIC BLOOD & CANCER (2016)
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity
Elad Jacoby et al.
NATURE COMMUNICATIONS (2016)
Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy
Fabiana Perna et al.
TRANSLATIONAL CANCER RESEARCH (2016)
Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells
Andrew G. Evans et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study
Alexandar Tzankov et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis
Wei Liu et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage
L. Slamova et al.
LEUKEMIA (2014)
Incidence and Clinical Significance of Aberrant T-Cell Marker Expression on Diffuse Large B-Cell Lymphoma Cells
Yuhko Suzuki et al.
ACTA HAEMATOLOGICA (2013)
Clinicopathologic Features of CD5-Positive Nodal Marginal Zone Lymphoma
Jesse Manuel Jaso et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Hacking cell differentiation: transcriptional rerouting in reprogramming, lineage infidelity and metaplasia
Goncalo Regalo et al.
EMBO MOLECULAR MEDICINE (2013)
Lineage switch from pro-B acute lymphoid leukemia to acute myeloid leukemia in a case with t(12;17)(p13;q11)/TAF15-ZNF384 rearrangement
Sara Grammatico et al.
LEUKEMIA & LYMPHOMA (2013)
Lineage switch in childhood acute leukemia: An unusual event with poor outcome
Jorge G. Rossi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Clinicopathologic Features of B-Cell Lineage Neoplasms With Aberrant Expression of CD3 A Study of 21 Cases
Jennifer L. Oliveira et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Extracavitary KSHV-associated Large B-Cell Lymphoma A Distinct Entity or a Subtype of Primary Effusion Lymphoma? Study of 9 Cases and Review of an Additional 43 Cases
Zeng-Gang Pan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia
Lucile Baseggio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
CD5-positive mucosa-associated lymphoid tissue (MALT) Lymphoma: a clinicopathologic study of 14 cases
Jesse Jaso et al.
HUMAN PATHOLOGY (2012)
Lineage Switching in Acute Leukemias: A Consequence of Stem Cell Plasticity?
Elisa Dorantes-Acosta et al.
BONE MARROW RESEARCH (2012)
Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells
Paul V. Beum et al.
JOURNAL OF IMMUNOLOGY (2011)
Aberrant Expression of CD8 in B-Cell Non-Hodgkin Lymphoma
Giovanni Carulli et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance
Junji Hiraga et al.
BLOOD (2009)
CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure
Nathalie A. Johnson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Anaplastic Lymphoma Kinase-Positive Diffuse Large B-Cell Lymphoma: A Rare Clinicopathologic Entity With Poor Prognosis
Camille Laurent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cell Lineages and the Logic of Proliferative Control
Arthur D. Lander et al.
PLOS BIOLOGY (2009)
Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia
Junping Wei et al.
CANCER CELL (2008)
Gastric MALT lymphoma with t(14;18)( q32; q21) involving IGH and BCL2 genes that responded to Helicobacter pylori eradication
Shotaro Nakamura et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearragement
M. W. J. C. Jansen et al.
LEUKEMIA (2007)
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia
Michael E. Williams et al.
JOURNAL OF IMMUNOLOGY (2006)
Molecular analysis of light-chain switch and acute lymphoblastic leukemia transformation in two follicular lymphomas: Implications for lymphomagenesis
Carol Kobrin et al.
LEUKEMIA & LYMPHOMA (2006)
Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia
AD Kennedy et al.
JOURNAL OF IMMUNOLOGY (2004)
Stepwise reprogramming of B cells into macrophages
HF Xie et al.
CELL (2004)
CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma:: a new case report and review of the literature
T Alvaro-Naranjo et al.
ANNALS OF HEMATOLOGY (2003)
Natural selection of tumor variants in the generation of tumor escape phenotypes
HT Khong et al.
NATURE IMMUNOLOGY (2002)
Pyothorax-associated lymphoma -: A peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype
B Petitjean et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
SA Armstrong et al.
NATURE GENETICS (2002)
Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab
T Pickartz et al.
EXPERIMENTAL HEMATOLOGY (2001)
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis
JM Foran et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
IgH, TCR-γ, and TCR-β gene rearrangement in 80 B- and T-cell non-Hodgkin's lymphoma:: Study of the association between proliferation and the so-called aberrant patterns
MJ García et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2001)
Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphoma
T Inaba et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia
C Cobaleda et al.
BLOOD (2000)
分享论文
